Biji Mathew1, Jacqueline N Poston2, John C Dreixler2, Leianne Torres1, Jasmine Lopez1, Ruth Zelkha3, Irina Balyasnikova4, Maciej S Lesniak4, Steven Roth5,6. 1. Department of Anesthesiology, University of Illinois Medical Center, 1740 West Taylor Street, MC 515, Chicago, IL, 60612, USA. 2. Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA. 3. Department of Ophthalmology, University of Illinois at Chicago, Chicago, IL, USA. 4. Department of Neurosurgery, Northwestern University, Chicago, IL, USA. 5. Department of Anesthesiology, University of Illinois Medical Center, 1740 West Taylor Street, MC 515, Chicago, IL, 60612, USA. rothgas@uic.edu. 6. Department of Ophthalmology, University of Illinois at Chicago, Chicago, IL, USA. rothgas@uic.edu.
Abstract
PURPOSE: Ischemia-associated retinal degeneration is one of the leading causes of vision loss, and to date, there are no effective treatment options. We hypothesized that delayed injection of bone-marrow stem cells (BMSCs) 24 h after the onset of ischemia could effectively rescue ischemic retina from its consequences, including apoptosis, inflammation, and increased vascular permeability, thereby preventing retinal cell loss. METHODS: Retinal ischemia was induced in adult Wistar rats by increasing intraocular pressure (IOP) to 130-135 mmHg for 55 min. BMSCs harvested from rat femur were injected into the vitreous 24 h post-ischemia. Functional recovery was assessed 7 days later using electroretinography (ERG) measurements of the a-wave, b-wave, P2, scotopic threshold response (STR), and oscillatory potentials (OP). The retinal injury and anti-ischemic effects of BMSCs were quantitated by measuring apoptosis, autophagy, inflammatory markers, and retinal-blood barrier permeability. The distribution and fate of BMSC were qualitatively examined using real-time fundus imaging, and retinal flat mounts. RESULTS: Intravitreal delivery of BMSCs significantly improved recovery of the ERG a- and b-waves, OP, negative STR, and P2, and attenuated apoptosis as evidenced by decreased TUNEL and caspase-3 protein levels. BMSCs significantly increased autophagy, decreased inflammatory mediators (TNF-α, IL-1β, IL-6), and diminished retinal vascular permeability. BMSCs persisted in the vitreous and were also found within ischemic retina. CONCLUSIONS: Taken together, our results indicate that intravitreal injection of BMSCs rescued the retina from ischemic damage in a rat model. The mechanisms include suppression of apoptosis, attenuation of inflammation and vascular permeability, and preservation of autophagy.
PURPOSE:Ischemia-associated retinal degeneration is one of the leading causes of vision loss, and to date, there are no effective treatment options. We hypothesized that delayed injection of bone-marrow stem cells (BMSCs) 24 h after the onset of ischemia could effectively rescue ischemic retina from its consequences, including apoptosis, inflammation, and increased vascular permeability, thereby preventing retinal cell loss. METHODS:Retinal ischemia was induced in adult Wistar rats by increasing intraocular pressure (IOP) to 130-135 mmHg for 55 min. BMSCs harvested from rat femur were injected into the vitreous 24 h post-ischemia. Functional recovery was assessed 7 days later using electroretinography (ERG) measurements of the a-wave, b-wave, P2, scotopic threshold response (STR), and oscillatory potentials (OP). The retinal injury and anti-ischemic effects of BMSCs were quantitated by measuring apoptosis, autophagy, inflammatory markers, and retinal-blood barrier permeability. The distribution and fate of BMSC were qualitatively examined using real-time fundus imaging, and retinal flat mounts. RESULTS: Intravitreal delivery of BMSCs significantly improved recovery of the ERG a- and b-waves, OP, negative STR, and P2, and attenuated apoptosis as evidenced by decreased TUNEL and caspase-3 protein levels. BMSCs significantly increased autophagy, decreased inflammatory mediators (TNF-α, IL-1β, IL-6), and diminished retinal vascular permeability. BMSCs persisted in the vitreous and were also found within ischemic retina. CONCLUSIONS: Taken together, our results indicate that intravitreal injection of BMSCs rescued the retina from ischemic damage in a rat model. The mechanisms include suppression of apoptosis, attenuation of inflammation and vascular permeability, and preservation of autophagy.
Authors: Steven F Abcouwer; Cheng-mao Lin; Ellen B Wolpert; Sumathi Shanmugam; Eric W Schaefer; Willard M Freeman; Alistair J Barber; David A Antonetti Journal: Invest Ophthalmol Vis Sci Date: 2010-06-16 Impact factor: 4.799
Authors: John C Dreixler; Jacqueline N Poston; Irina Balyasnikova; Afzhal R Shaikh; Kelsey Y Tupper; Sineadh Conway; Venkat Boddapati; Marcus M Marcet; Maciej S Lesniak; Steven Roth Journal: Invest Ophthalmol Vis Sci Date: 2014-04-03 Impact factor: 4.799
Authors: R Russo; L Berliocchi; A Adornetto; G P Varano; F Cavaliere; C Nucci; D Rotiroti; L A Morrone; G Bagetta; M T Corasaniti Journal: Cell Death Dis Date: 2011-04-14 Impact factor: 8.469
Authors: Henry Caplan; Scott D Olson; Akshita Kumar; Mitchell George; Karthik S Prabhakara; Pamela Wenzel; Supinder Bedi; Naama E Toledano-Furman; Fabio Triolo; Julian Kamhieh-Milz; Guido Moll; Charles S Cox Journal: Front Immunol Date: 2019-07-31 Impact factor: 7.561
Authors: Elena Redondo-Castro; Catriona J Cunningham; Jonjo Miller; Stuart A Cain; Stuart M Allan; Emmanuel Pinteaux Journal: Bio Protoc Date: 2018-08-20
Authors: Elena Redondo-Castro; Catriona J Cunningham; Jonjo Miller; Helena Brown; Stuart M Allan; Emmanuel Pinteaux Journal: Stem Cell Res Ther Date: 2018-01-17 Impact factor: 6.832